In these rare cases, in which PV is suspected and/or the WHO diagnostic criteria are met despite the absence of a detectable JAK2 mutation, a somatic myeloid NGS panel can help with PV diagnosis in addition to research on noncanonical nucleotide changes leading to V617F or compound mutations in exon 14 [42,43]. Here, JAK2 is linked to acquired polycythemia vera.